PMC10313222_01
The structure of HNF1A gene and the patient specific genetic variant: nucleotide 416 in the coding DNA changed from Thymine (T) to Cytosine (C) leading to amino acid change in position 139 in the protein sequence, from Leucine to Proline. E1, Exon1.
fendo-14-1173471-g001.jpg
PMC10313222_01_fendo-14-1173471-g001.jpg
f1
Leu139Pro),  Figure 1 .
PMC10313222_02
The patient's CGM (Libre 2) report in the 2 weeks following insulin discontinuation.
fendo-14-1173471-g002.jpg
PMC10313222_02_fendo-14-1173471-g002.jpg
f2
Two weeks after the discontinuation of his insulin therapy, his CGM metrics showed a time in range (70-180 mg/dL) of 95%, time above range (181-250 mg/dL) of 4%, and time below range (54-69mg/dL) of 1%,  Figure 2 .
The patient's timeline from diabetes mellitus diagnosis until today. *Diabetes antibodies: glutamic acid decarboxylase antibodies, anti-insulin antibodies, ant-islet cell antibodies, zinc transporter 8 antibodies. VUS, variant of uncertain significance.
fendo-14-1173471-g003.jpg
PMC10313222_02_fendo-14-1173471-g003.jpg
f3
He has remained off insulin therapy for 7 months and maintains his glycemia on diet alone.  Figure 3 .